Sonodynamic cancer therapy: A non-invasive and repeatable approach using low-intensity ultrasound with a sonosensitizer

Anticancer Research

Volumn 31, Issue 7, 2011, Pages 2425-2430

  Shibaguchi, Hirotomo ^a   Tsuru, Hirofumi ^a   Kuroki, Motomu ^a   Kuroki, Masahide ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Low intensity ultrasound; Review; Sonodynamic therapy; Sonosensitizers

Indexed keywords

AMINOLEVULINIC ACID; ATX 70; PHOTOFRIN; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN; REACTIVE OXYGEN METABOLITE; TITANIUM DEOXIDE; UNCLASSIFIED DRUG;

CANCER CELL CULTURE; CANCER THERAPY; CELL MEMBRANE; DRUG DELIVERY SYSTEM; GENE THERAPY; GLIOMA; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; LOW ENERGY RADIATION; MELANOMA; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; REVIEW; SONODYNAMIC THERAPY; STOMACH CANCER; TEMPERATURE; ULTRASOUND;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; GENE THERAPY; HUMANS; LIPOSOMES; MICROBUBBLES; NANOCAPSULES; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; T-LYMPHOCYTES, CYTOTOXIC; ULTRASONIC THERAPY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 79961196721     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Ackroyd R, Kelty C, Brown N and Reed M: The history of photodetection and photodynamic therapy. Photochem Photobiol 74: 656-669, 2001.
2. Roelandts R: The history of phototherapy: something new under the sun? J Am Acad Dermatol 46: 926-930, 2002.
3. Wilson BC and Patterson MS: The physics, biophysics and technology of photodynamic therapy. Phys Med Biol 53: R61-109, 2008.
4. Morton CA, McKenna KE and Rhodes LE: Guidelines for topical photodynamic therapy: update. Br J Dermatol 159: 1245-1266, 2008.
5. O'Connor AE, Gallagher WM and Byrne AT: Porphyrin and nonporphyrin photosensitizers in oncology: preclinical and clinical advances in photodynamic therapy. Photochem Photobiol 85: 1053-1074, 2009.
6. Buettner GR: Thiyl free radical production with hematoporphyrin derivative, cysteine and light: a spin-trapping study. FEBS Lett 177: 295-299, 1984.
7. Robertson CA, Evans DH and Abrahamse H: Photodynamic therapy (PDT): a short review on cellular mechanisms and cancer research applications for PDT. J Photochem Photobiol B 96: 1-8, 2009.
8. Triesscheijn M, Baas P, Schellens JH and Stewart FA: Photodynamic therapy in oncology. Oncologist 11: 1034-1044, 2006. (Pubitemid 44564813)
9. Reiners JJ, Jr., Agostinis P, Berg K, Oleinick NL and Kessel D: Assessing autophagy in the context of photodynamic therapy. Autophagy 6: 7-18, 2010.
10. Buytaert E, Callewaert G, Hendrickx N, Scorrano L, Hartmann D, Missiaen L, Vandenheede JR, Heirman I, Grooten J and Agostinis P: Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy. FASEB J 20: 756-758, 2006. (Pubitemid 46671205)
11. Buytaert E, Dewaele M and Agostinis P: Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim Biophys Acta 1776: 86-107, 2007. (Pubitemid 47332075)
12. Morgan J and Oseroff AR: Mitochondria-based photodynamic anticancer therapy. Adv Drug Deliv Rev 49: 71-86, 2001.
13. Nielsen KP, Juzeniene A, Juzenas P, Stamnes K, Stamnes JJ and Moan J: Choice of optimal wavelength for PDT: the significance of oxygen depletion. Photochem Photobiol 81: 1190-1194, 2005. (Pubitemid 41545945)
14. Moriwaki SI, Misawa J, Yoshinari Y, Yamada I, Takigawa M and Tokura Y: Analysis of photosensitivity in Japanese cancer-bearing patients receiving photodynamic therapy with porfimer sodium (Photofrin). Photodermatol Photoimmunol Photomed 17: 241-243, 2001. (Pubitemid 32834293)
15. Suslick KS: Sonochemistry. Science 247: 1439-1445, 1990.
16. Didenko YT, McNamara WB, 3rd and Suslick KS: Molecular emission from single-bubble sonoluminescence. Nature 407: 877-879, 2000.
17. Lindner U, Trachtenberg J and Lawrentschuk N: Focal therapy in prostate cancer: modalities, findings and future considerations. Nat Rev Urol 7: 562-571, 2010.
18. Ahmed HU, Moore C and Emberton M: Minimally-invasive technologies in uro-oncology: the role of cryotherapy, HIFU and photodynamic therapy in whole gland and focal therapy of localised prostate cancer. Surg Oncol 18: 219-232, 2009.
19. Chopra R, Burtnyk M, N'Djin WA and Bronskill M: MRI-controlled transurethral ultrasound therapy for localised prostate cancer. Int J Hyperthermia 26: 804-821, 2010.
20. Padma S, Martinie JB and Iannitti DA: Liver tumor ablation: percutaneous and open approaches. J Surg Oncol 100: 619-634, 2009.
21. Lammers T, Kiessling F, Hennink WE and Storm G: Nanotheranostics and image-guided drug delivery: current concepts and future directions. Mol Pharm 7: 1899-1912, 2010.
22. Shim MS and Kwon YJ: Efficient and targeted delivery of siRNA in vivo. FEBS J 277: 4814-4827, 2010.
23. Weinberg BD, Blanco E and Gao J: Polymer implants for intratumoral drug delivery and cancer therapy. J Pharm Sci 97: 1681-1702, 2008.
24. Tezel A, Sens A, Tuchscherer J and Mitragotri S: Frequency dependence of sonophoresis. Pharm Res 18: 1694-1700, 2001.
25. Kushner JT, Blankschtein D and Langer R: Evaluation of hydrophilic permeant transport parameters in the localized and non-localized transport regions of skin treated simultaneously with low-frequency ultrasound and sodium lauryl sulfate. J Pharm Sci 97: 906-918, 2008. (Pubitemid 351293890)
26. WoUoch L and Kost J: The importance of microjet vs. shock wave formation in sonophoresis. J Control Release 148: 204-211, 2010.
27. Husseini GA and Pitt WG: Micelles and nanoparticles for ultrasonic drug and gene delivery. Adv Drug Deliv Rev 60: 1137-1152, 2008.
28. Schroeder A, Kost J and Barenholz Y: Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes. Chem Phys Lipids 162: 1-16, 2009.
29. Suzuki R, Oda Y, Utoguchi N and Maruyama K: Progress in the development of ultrasound-mediated gene delivery systems utilizing nano- and microbubbles. J Control Release 149: 36-41, 2011.
30. Hernot S and Klibanov AL: Microbubbles in ultrasound-triggered drug and gene delivery. Adv Drug Deliv Rev 60: 1153-1166, 2008.
31. Nelson JL, Roeder BL, Carmen JC, Roloff F and Pitt WG: Ultrasonically activated chemotherapeutic drug delivery in a rat model. Cancer Res 62: 7280-7283, 2002. (Pubitemid 36025250)
32. Myhr G and Moan J: Synergistic and tumour selective effects of chemotherapy and ultrasound treatment. Cancer Lett 232: 206-213, 2006.
33. Suzuki R, Namai E, Oda Y, Nishiie N, Otake S, Koshima R, Hirata K, Taira Y, Utoguchi N, Negishi Y, Nakagawa S and Maruyama K: Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure. J Control Release 142: 245-250, 2010.
34. Suzuki R, Oda Y, Utoguchi N, Namai E, Taira Y, Okada N, Kadowaki N, Kodama T, Tachibana K and Maruyama K: A novel strategy utilizing ultrasound for antigen delivery in dendritic cell-based cancer immunotherapy. J Control Release 133: 198-205, 2009.
35. Yumita N, Nishigaki R, Umemura K and Umemura S: Hematoporphyrin as a sensitizer of cell-damaging effect of ultrasound. Jpn J Cancer Res 80: 219-222, 1989. (Pubitemid 20027211)
36. Miyoshi N, Misik V, Fukuda M and Riesz P: Effect of gallium-porphyrin analogue ATX-70 on nitroxide formation from a cyclic secondary amine by ultrasound: on the mechanism of sonodynamic activation. Radiat Res 143: 194-202, 1995.
37. Rosenthal I, Sostaric JZ and Riesz P: Sonodynamic therapy - a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem 11: 349-363, 2004. (Pubitemid 39070478)
38. Hachimine K, Shibaguchi H, Kuroki M, Yamada H, Kinugasa T, Nakae Y, Asano R, Sakata I, Yamashita Y and Shirakusa T: Sonodynamic therapy of cancer using a novel porphyrin derivative, DCPH-P-Na(I), which is devoid of photosensitivity. Cancer Sci 98: 916-920, 2007.
39. Yamaguchi S, Kobayashi H, Narita T, Kanehira K, Sonezaki S, Kudo N, Kubota Y, Terasaka S and Houkin K: Sonodynamic therapy using water-dispersed TiO(2)-polyethylene glycol compound on glioma cells: Comparison of cytotoxic mechanism with photodynamic therapy. Ultrason Sonochem 18: 1197-1204, 2010.
40. Yumita N, Okuyama N, Sasaki K and Umemura S: Sonodynamic therapy on chemically induced mammary tumor: pharmacokinetics, tissue distribution and sonodynamically induced antitumor effect of gallium-porphyrin complex ATX-70. Cancer Chemother Pharmacol 60: 891-897, 2007. (Pubitemid 47389395)
41. Yumita N, Okuyama N, Sasaki K and Umemura S: Sonodynamic therapy on chemically induced mammary tumor: pharmacokinetics, tissue distribution and sonodynamically induced antitumor effect of porfimer sodium. Cancer Sci 95: 765-769, 2004. (Pubitemid 39335098)
42. Wang X, Wang Y, Wang P, Cheng X and Liu Q: Sonodynamically induced antitumor effect with protoporphyrin IX on hepatoma-22 solid tumor. Ultrasonics 51: 539-546, 2011.
43. Ohmura T, Fukushima T, Shibaguchi H, Yoshizawa S, Inoue T, Kuroki M, Sasaki K and Umemura S: Sonodynamic therapy with 5-aminolevulinic acid and focused ultrasound for deep seated intracranial glioma in rat. Anticancer Res in press, 2011.
44. Hefti M, von Campe G, Moschopulos M, Siegner A, Looser H and Landolt H: 5-Aminolevulinic acid induced protoporphyrin IX fluorescence in high-grade glioma surgery: a one-year experience at a single institutuion. Swiss Med Wkly 138: 180-185, 2008.
45. 2 in melanoma tumors. J Control Release 149: 190-195, 2011.
46. Ashikaga T, Wada M, Kobayashi H, Mori M, Katsumura Y, Fukui H, Kato S, Yamaguchi M and Takamatsu T: Effect of the photocatalytic activity of TiO(2) on plasmid DNA. Mutat Res 466: 1-7, 2000. (Pubitemid 30177132)
47. 2). Ultrasound Med Biol 32: 147-152, 2006.
48. Yumita N, Iwase Y, Nishi K, Ikeda T, Komatsu H, Fukai T, Onodera K, Nishi H, Takeda K, Umemura S, Okudaira K and Momose Y: Sonodynamically-induced antitumor effect of mono-1-aspartyl chlorin e6 (NPe6). Anticancer Res 31: 501-506, 2011.